Response of mice and ferrets to a monovalent influenza a (H7N9) split vaccine

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Duan, Yueqiang ^a   Gu, Hongjing ^a   Chen, Rui ^a,b   Zhao, Zhongpeng ^a   Zhang, Liangyan ^a   Xing, Li ^a   Lai, Chengcai ^a   Zhang, Peirui ^c   Li, Zhiwei ^c   Zhang, Keming ^c   Wang, Zhouhai ^c   Zhang, Shaogeng ^c   Wang, Xiliang ^a   Yang, Penghui ^a,c  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c 302 MILITARY HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; SIALIDASE; LIVE VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CHICKEN; CHINA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FERRET; GENETIC CODE; GENETIC REASSORTMENT; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A H7N9; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PATHOGENICITY; TREATMENT RESPONSE; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; CHLOROCEBUS AETHIOPS; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA, HUMAN; REVERSE GENETICS; ULTRASTRUCTURE; VACCINATION; VERO CELL LINE; VIROLOGY; VIRUS CAPSID; VIRUS REPLICATION;

ANIMALS; CAPSID; CERCOPITHECUS AETHIOPS; CHICKENS; FEMALE; FERRETS; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE, INBRED BALB C; REVERSE GENETICS; VACCINATION; VACCINES, ATTENUATED; VERO CELLS; VIRUS REPLICATION;

EID: 84903289136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099322     Document Type: Article

References (26)

1. Shu Y (2013) Human infection with H7N9 virus. The New England journal of medicine 369: 880.
2. Gao R, Cao B, Hu Y, Feng Z, Wang D, et al. (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. The New England journal of medicine 368: 1888-1897.
3. Chen Y, Liang W, Yang S, Wu N, Gao H, et al. (2013) Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 381: 1916-1925.
4. Gao HN, Lu HZ, Cao B, Du B, Shang H, et al. (2013) Clinical findings in 111 cases of influenza A (H7N9) virus infection. The New England journal of medicine 368: 2277-2285.
5. De Groot AS, Ardito M, Terry F, Levitz L, Ross T, et al. (2013) Low immunogenicity predicted for emerging avian-origin H7N9: Implication for influenza vaccine design. Human vaccines & immunotherapeutics 9: 950-956.
6. Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, et al. (2004) Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363: 1099-1103. (Pubitemid 38452781)
7. Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, et al. (2009) Response to a monovalent 2009 influenza A (H1N1) vaccine. The New England journal of medicine 361: 2405-2413.
8. Li Q, Zhou L, Zhou M, Chen Z, Li F, et al. (2013) Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China. The New England journal of medicine.
9. Zhu H, Wang D, Kelvin DJ, Li L, Zheng Z, et al. (2013) Infectivity, transmission, and pathology of human-isolated H7N9 influenza virus in ferrets and pigs. Science 341: 183-186.
10. Liu D, Shi W, Shi Y, Wang D, Xiao H, et al. (2013) Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381: 1926-1932.
11. Hoffmann E, Neumann G, Kawaoka Y, Hobom G and Webster RG (2000) A DNA transfection system for generation of influenza A virus from eight plasmids. Proceedings of the National Academy of Sciences of the United States of America 97: 6108-6113. (Pubitemid 30367531)
12. Harvey R, Wheeler JX, Wallis CL, Robertson JS and Engelhardt OG (2008) Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1). Vaccine 26: 6550-6554.
13. Osterholm MT, Ballering KS and Kelley NS (2013) Major challenges in providing an effective and timely pandemic vaccine for influenza A(H7N9). JAMA: the journal of the American Medical Association 309: 2557-2558.
14. Shaw A (2012) New technologies for new influenza vaccines. Vaccine 30: 4927-4933.
15. Dormitzer PR, Tsai TF and Del Giudice G (2012) New technologies for influenza vaccines. Human vaccines & immunotherapeutics 8: 45-58.
16. Subbarao K, Chen H, Swayne D, Mingay L, Fodor E, et al. (2003) Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305: 192-200. (Pubitemid 36062823)
17. Pleschka S, Jaskunas R, Engelhardt OG, Zurcher T, Palese P, et al. (1996) A plasmid-based reverse genetics system for influenza A virus. J Virol 70: 4188-4192. (Pubitemid 26157406)
18. Neumann G, Fujii K, Kino Y and Kawaoka Y (2005) An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proceedings of the National Academy of Sciences of the United States of America 102: 16825-16829. (Pubitemid 41688861)
19. Jing X, Phy K, Li X and Ye Z (2012) Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains. Vaccine 30: 4144-4152.
20. Wanitchang A, Kramyu J and Jongkaewwattana A (2010) Enhancement of reverse genetics-derived swine-origin H1N1 influenza virus seed vaccine growth by inclusion of indigenous polymerase PB1 protein. Virus Res 147: 145-148.
21. Zhou J, Wang D, Gao R, Zhao B, Song J, et al. (2013) Biological features of novel avian influenza A (H7N9) virus. Nature 499: 500-503.
22. Smith GE, Flyer DC, Raghunandan R, Liu Y, Wei Z, et al. (2013) Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus. Vaccine 31: 4305-4313.
23. Fries LF, Smith GE and Glenn GM (2013) A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine. The New England journal of medicine.
24. Krammer F, Margine I, Hai R, Flood A, Hirsh A, et al. (2013) H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J Virol.
25. Yang P, Duan Y, Wang C, Xing L, Gao X, et al. (2011) Immunogenicity and protective efficacy of a live attenuated vaccine against the 2009 pandemic A H1N1 in mice and ferrets. Vaccine 29: 698-705.
26. Xu L, Bao L, Deng W, Dong L, Zhu H, et al. (2013) Novel Avian-Origin Human Influenza A(H7N9) Can Be Transmitted Between Ferrets via Respiratory Droplets. The Journal of infectious diseases.